manufacturer

Featured Health & Pharmaceuticals Marketing & Consulting

Actavis generic prostate cancer drug Bicalutamide first to market in UK, Germany, France

July 10, 2008July 27, 20152 min read

Reykjavik, Iceland, 10 July 2008 — Actavis Group, the international generic pharmaceuticals company, today announced the launch of Bicalutamide tablets in the United Kingdom, Germany

Tag: manufacturer

Actavis generic prostate cancer drug Bicalutamide first to market in UK, Germany, France

You May Have Missed

Mental Wellness Platform Attracts Fulbright Canada President and Leading Researchers to Advisory Board Ahead of Global Launch

Apprentice Engineers Welcome MP to Mark National Apprenticeship Week 2026

Armor Bank Unveils New ArmorBank.com, Advancing Its Commitment to Good Faith Banking, For All Good People

Simplifying Medical Billing: Easy Billing Services Leads the Way